Medreleaf

Aktie
WKN:  A2DTAQ ISIN:  CA58506X1042
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-
Medreleaf Chart
Werbung

Mehr Nachrichten kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Termine

Keine Termine bekannt.

Prognose & Kursziel

Keine aktuellen Prognosen oder Kursziele bekannt.

Stammdaten

Aktienanzahl 90,39 Mio.
Aktientyp Stammaktie

Community-Beiträge zu Medreleaf

  • Community-Beiträge
  • Aktuellste Threads
Avatar des Verfassers
bradetti
Na guck mal an: NEWS
MedReleaf receives license amendment from Health Canada to commence sales at its Bradford Facility https://www.tmxmoney.com/en/news/company_releases/index.html?rkey=20171106C7678&filter=8242 Vorbörslich soeben rausgekommen!!
Avatar des Verfassers
chinasky
Q.4/ Fiscal Year 2017 - Conference Call - 28.06.17
Zitat:"MARKHAM, ON, June 16, 2017 /CNW/ - MedReleaf Corp. (TSX: LEAF), Canada's first and only ISO 9001 certified cannabis producer, today announced that it will hold a conference call to discuss its fourth quarter and fiscal year 2017 results on Wednesday, June 28, 2017 at 8:00 a.m. (ET). The call will be hosted by Neil Closner, Chief Executive Officer, and Igor Gimelshtein, Chief Financial Officer, followed by a question and answer period. MedReleaf will report its financial results in the morning prior to the call." ENDE Zitat https://investors.medreleaf.com/press-releases/press-release-details/2017/MedReleaf-Corp-to-Host-Fourth-Quarter-and-Fiscal-Year-2017-Conference-Call/default.aspx
Avatar des Verfassers
chinasky
(unknown) Analyst Coverage - Buy Target C$14,-
Zitat:" Initiating coverage: MedReleaf Corp. BUY- LEAF-TSX, June 14, 2017 Target: C$14.00 MedReleaf produces and sells medical cannabis in Canada. The company was one of the early applicants with Health Canada, providing it with a first mover advantage. MedReleaf’s profitability is impressive with trailing twelve months EBITDA levels that exceed all of the other public peers combined. The company’s products are well perceived by users enabling MedReleaf to charge a premium price. This, combined with the lowest production costs in the industry, explains the company’s high profitability......Proceeds from the IPO will be used to fund expansion at the Bradford facility......which is expected to quadruple MedReleaf’s capacity to 35,000kg annually.This is expected to support the company’s entrance in the recreational market which, at $5b, is expected to be 10x larger than the medical market. We are initiating coverage of LEAF with a BUY....." ENDE Zitat Full Article/Source:http://www.stockhouse.com/companies/bullboard?symbol=t.leaf&postid=26378981
Avatar des Verfassers
chinasky
Widerspruch gegen Moderation abgelehnt ;-)
Jetzt anmelden und diskutieren Registrieren Login
Zum Thread wechseln

Häufig gestellte Fragen zur Medreleaf Aktie und zum Medreleaf Kurs

Nein, Medreleaf zahlt keine Dividenden.